MetaADEDB 2.0 @ LMMD
[(8S,9S,10R,13S,14S,17R)-17-Hydroxy-17-(2-hydroxyacetyl)-1,10,13-trimethyl-3,11-dioxo-6,7,8,9,12,14,15,16-octahydrocyclopenta[a]phenanthren-2-yl] acetate
(KTEYBOYPFHMFAO-JBSZYYGASA-N)
Structure
SMILES
OCC(=O)[C@@]1(O)CC[C@@H]2[C@]1(C)CC(=O)[C@H]1[C@H]2CCC2=CC(=O)C(=C([C@]12C)C)OC(=O)C
Molecular Formula:
C24H30O7
Molecular Weight:
430.491
Log P:
2.0467
Hydrogen Bond Acceptor:
7
Hydrogen Bond Donor:
2
TPSA:
117.97
CAS Number(s):
N/A
Synonym(s)
1.
[(8S,9S,10R,13S,14S,17R)-17-Hydroxy-17-(2-hydroxyacetyl)-1,10,13-trimethyl-3,11-dioxo-6,7,8,9,12,14,15,16-octahydrocyclopenta[a]phenanthren-2-yl] acetate
External Link(s)
PubChem Compound129651258
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1AlopeciaFAERS: 1US FAERS
2AneurysmFAERS: 1US FAERS
3ArachnoiditisFAERS: 1US FAERS
4Cerebrovascular accidentFAERS: 1US FAERS
5PainFAERS: 1US FAERS
6Product contaminationFAERS: 1US FAERS
7Urinary IncontinenceFAERS: 1US FAERS
8Weight decreasedFAERS: 1US FAERS
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120239

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.